Abstract
Not all patients have benefited equally from the advances in non-Hodgkin lymphoma (NHL) survival. This study investigates several individual-level markers of socioeconomic position (SEP) in relation to NHL survival, and explores whether any social differences could be attributed to comorbidity, disease and prognostic factors, or the treatment given.
Originalsprog | Engelsk |
---|---|
Tidsskrift | B J C |
Vol/bind | 106 |
Udgave nummer | 5 |
Sider (fra-til) | 988-95 |
Antal sider | 8 |
ISSN | 0007-0920 |
DOI | |
Status | Udgivet - 2012 |